Christopher D Verrico
Works at
Associate professor
Sources: reporter.nih.gov
Grants and prizes
National Institute on Drug Abuse
R01, A Randomized Controlled Trial of Exenatide as an Adjunct to Nicotine Patch for Smoking Cessation and Prevention of Post-Cessation Weight Gain, R01DA053241, 2022–2027, 19 May 2025
National Institute on Drug Abuse
R21, A Human Laboratory Study of Exenatide for Reducing the Reinforcing Effects of Cocaine, R21DA057411, 2023–2026, 16 Apr 2024
Sources: reporter.nih.gov